Clinical trial Recruiting at 5 sites Interventional Ages 20 Weeks to 45 Weeks

Effects of morphine and midazolam on sedation in neonates on mechanical ventilation

Official title: Pharmacokinetics-pharmacodynamics of Morphine With or Without Midazolam Administered by Continuous Infusion in Neonatal Intensive Care

Run by Centre Hospitalier Intercommunal Creteil · NCT05371886 · Data updated 2026-11-12

This study tests how well morphine and midazolam work together to keep babies on breathing machines comfortable and pain-free in the intensive care unit.

More Sedation Complication trials

Quick facts

Study typeInterventional
Ages20 Weeks to 45 Weeks
SexAll
Enrollment180 (estimated)
SponsorCentre Hospitalier Intercommunal Creteil
Academic / other
Locations5 sites (Brest and 4 other locations)
StatusRecruiting
StartedApril 1, 2023
Main results expectedJuly 1, 2023
Study endsMay 1, 2027
Registry record updatedNovember 17, 2025
Trial IDNCT05371886 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are neonates under 45 weeks of corrected gestational age who are hospitalized in a Neonatal Intensive Care Unit and undergoing mechanical ventilation.

Probably not a fit

Patients who are under palliative care or have undergone recent surgical procedures may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the pharmacokinetics and pharmacodynamics of morphine, both alone and in combination with midazolam, administered via continuous infusion to neonates in intensive care who are undergoing mechanical ventilation. It will assess the comfort and pain levels of these infants using specific scoring systems while measuring drug concentrations through blood tests. The goal is to establish a dose-effect relationship and understand the variability in drug response among neonates based on individual characteristics such as gestational age and weight.

Why it matters

Potential benefit: If successful, this study could lead to improved sedation management in neonates, enhancing their comfort during mechanical ventilation.

How similar studies have gone: Other studies have explored similar pharmacokinetic and pharmacodynamic relationships in neonates, but this specific combination of drugs and methodology may provide novel insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Neonates \< 45 weeks of corrected gestational age
* Hospitalized in a Neonatal Intensive Care Unit
* Undergoing mechanical ventilation
* Patients that receive morphine alone or morphine and midazolam as continuous infusion
* Affiliated to a social security system

Exclusion Criteria:

* Current weight \< 600g
* Neonates under palliative care
* Therapeutic hypothermia for perinatal anoxia
* Neonates who underwent a surgical procedure during the past 72 hours
* Neonates receiving concomitantly a paralytic or another drug for sedation or analgesia other than morphine or midazolam (except for paracetamol/acetaminophen)
* Parents refusing that their child participate

Where it's running

  • CHRU Morvan
    Brest, France
    Recruiting
  • CH SUD Francilien
    Corbeil-Essonnes, France
    Recruiting
  • CHI Créteil
    Créteil, France
    Recruiting
  • CHU Lille
    Lille, France
    Recruiting
  • CHU Tours
    Tours, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.